Myoepithelial Carcinoma arising from a Parotid Pleomorphic Adenoma A Case Report

Myoepithelial carcinoma is a rare neoplasm, accounting for less than 2% of all salivary gland carcinomas and can arise de novo or secondary to a previous pleomorphic adenoma, as in the case presented here. The presence of mitoses, foci of necrosis, characteristic histomorphology, and exclusive proliferation of myoepithelial cells identified by immunohistochemistry confirm the diagnosis. The gold standard of therapy is surgical resection with clear margins; however, the risks of local recurrence and distant metastasis are 35% and 22%, respectively. Our case corresponds to a 65-year-old patient who underwent surgery for a pleomorphic adenoma, which recurred after 5 years. She presented to our clinic with a myoepithelial tumor of 2 months’ evolution with involvement of the facial nerve and soft tissues. Due to its rapid growth, this is an unusual presentation.

Authors

Publication Details

Journal
Journal of Cancer Research Reviews & Reports
Published
2024-08-31
DOI
https://doi.org/10.47363/jcrr/2024(6)198
Primary Topic
Salivary Gland Tumors Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Myoepithelial Carcinoma arising from a Parotid Pleomorphic Adenoma A Case Report

D’Addino José Luis
Journal of Cancer Research Reviews & Reports
Salivary Gland Tumors Diagnosis and Treatment
article

Myoepithelial Carcinoma arising from a Parotid Pleomorphic Adenoma A Case Report

D’Addino José Luis
article en

Abstract

Myoepithelial carcinoma is a rare neoplasm, accounting for less than 2% of all salivary gland carcinomas and can arise de novo or secondary to a previous pleomorphic adenoma, as in the case presented here. The presence of mitoses, foci of necrosis, characteristic histomorphology, and exclusive proliferation of myoepithelial cells identified by immunohistochemistry confirm the diagnosis. The gold standard of therapy is surgical resection with clear margins; however, the risks of local recurrence and distant metastasis are 35% and 22%, respectively. Our case corresponds to a 65-year-old patient who underwent surgery for a pleomorphic adenoma, which recurred after 5 years. She presented to our clinic with a myoepithelial tumor of 2 months’ evolution with involvement of the facial nerve and soft tissues. Due to its rapid growth, this is an unusual presentation.

Journal of Cancer Research Reviews & Reports
Openalex Percentile: Top 67%
Salivary Gland Tumors Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.